bismuth subsalicylate 262 MG Powder for Oral Suspension [Estomaquil]
- RxCUI
- 1721455
- RxNorm name
- bismuth subsalicylate 262 MG Powder for Oral Suspension [Estomaquil]
- Term type
- SBD
- Status
- Active
- Updated
- 2026-11-02 18:15:52
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122015
- Active start
- 122015
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| bismuth subsalicylate | 262 MG / 1 EACH | bismuth subsalicylate | bismuth subsalicylate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Powder for Oral Suspension | 1540456 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| bismuth subsalicylate | 19478 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | Estomaquil 262 MG Powder for Oral Suspension | 1 | NAMES |
| RxNorm Name | bismuth subsalicylate 262 MG Powder for Oral Suspension [Estomaquil] | 1 | NAMES |
| RxNorm Synonym | Estomaquil 262 MG Powder for Oral Suspension | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | cf94c99a-c489-45ec-bb13-3e6959e377de | 1 | CODES |
| RxCUI | 1721455 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 58988-1080-1 | 58988-1080 | Estomaquil Polvo BISMUTH SUBSALICYLATE | ProMex LLC | M008 |
| 58988-1080-2 | 58988-1080 | Estomaquil Polvo BISMUTH SUBSALICYLATE | ProMex LLC | M008 |
| 58988-1080-3 | 58988-1080 | Estomaquil Polvo BISMUTH SUBSALICYLATE | ProMex LLC | M008 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| M008 | 58988-1080 | Estomaquil Polvo BISMUTH SUBSALICYLATE | OTC MONOGRAPH DRUG | ProMex LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Estomaquil Polvo | BISMUTH SUBSALICYLATE | ProMex LLC | cf94c99a-c489-45ec-bb13-3e6959e377de | 2023-11-29 | Warnings | 58988-1080-3 58988-1080-2 58988-1080-1 58988-1080 58988108002 58988108001 58988108003 1721455 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cf94c99a-c489-45ec-bb13-3e6959e377de | Estomaquil 262 MG Powder for Oral Suspension [PSN] · bismuth subsalicylate 262 MG Powder for Oral Suspension [Estomaquil] [SBD] · Estomaquil 262 MG Powder for Oral Suspension [SY] | 3 | 4 | Estomaquil ® Polvo | 20231129 |
| e272c1cf-9793-0abd-e053-2995a90a2229 | Estomaquil 262 MG Powder for Oral Suspension [PSN] · bismuth subsalicylate 262 MG Powder for Oral Suspension [Estomaquil] [SBD] · Estomaquil 262 MG Powder for Oral Suspension [SY] | 3 | 1 | Estomaquil ® Polvo | 20220627 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| cf94c99a-c489-45ec-bb13-3e6959e377de | Estomaquil ® Polvo | ProMex LLC | 20231129 |
| e272c1cf-9793-0abd-e053-2995a90a2229 | Estomaquil ® Polvo | All Natural Dynamics | 20220627 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| FDASPL | D001729 | Bismuth | CHEM | has_chemical_structure | bismuth subsalicylate |
| FDASPL | N0000180183 | Bismuth | EPC | has_epc | bismuth subsalicylate |
| MEDRT | D001729 | Bismuth | CHEM | has_ingredient | bismuth subsalicylate |
| MEDRT | D009942 | Organometallic Compounds | CHEM | has_ingredient | bismuth subsalicylate |
| MEDRT | D012459 | Salicylates | CHEM | has_ingredient | bismuth subsalicylate |
| MEDRT | D001778 | Blood Coagulation Disorders | DISEASE | ci_with | bismuth subsalicylate |
| MEDRT | D002644 | Chickenpox | DISEASE | ci_with | bismuth subsalicylate |
| MEDRT | D003967 | Diarrhea | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | bismuth subsalicylate |
| MEDRT | D004405 | Dysentery, Bacillary | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | ci_with | bismuth subsalicylate |
| MEDRT | D016481 | Helicobacter Infections | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D009325 | Nausea | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | bismuth subsalicylate |
| MEDRT | D013272 | Stomach Diseases | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | D014777 | Virus Diseases | DISEASE | may_treat | bismuth subsalicylate |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | bismuth subsalicylate |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | bismuth subsalicylate |
| MEDRT | N0000009724 | Inhibition Gastric Acid Secretion | PE | has_pe | bismuth subsalicylate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | ACTIVATED | 01/30/2024 |
| ATTRIBUTES | AVAILABLE_STRENGTH | 262 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | Estomaquil 262 MG Powder for Oral Suspension |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |